182 related articles for article (PubMed ID: 24615786)
1. Mitochondrial dysfunction and electron transport chain complex defect in a rat model of tenofovir disoproxil fumarate nephrotoxicity.
Ramamoorthy H; Abraham P; Isaac B
J Biochem Mol Toxicol; 2014 Jun; 28(6):246-55. PubMed ID: 24615786
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial tubulopathy in tenofovir disoproxil fumarate-treated rats.
Lebrecht D; Venhoff AC; Kirschner J; Wiech T; Venhoff N; Walker UA
J Acquir Immune Defic Syndr; 2009 Jul; 51(3):258-63. PubMed ID: 19582894
[TBL] [Abstract][Full Text] [Related]
3. Depletion of the cellular antioxidant system contributes to tenofovir disoproxil fumarate - induced mitochondrial damage and increased oxido-nitrosative stress in the kidney.
Abraham P; Ramamoorthy H; Isaac B
J Biomed Sci; 2013 Aug; 20(1):61. PubMed ID: 23957306
[TBL] [Abstract][Full Text] [Related]
4. Tenofovir renal proximal tubular toxicity is regulated by OAT1 and MRP4 transporters.
Kohler JJ; Hosseini SH; Green E; Abuin A; Ludaway T; Russ R; Santoianni R; Lewis W
Lab Invest; 2011 Jun; 91(6):852-8. PubMed ID: 21403643
[TBL] [Abstract][Full Text] [Related]
5. Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.
Herlitz LC; Mohan S; Stokes MB; Radhakrishnan J; D'Agati VD; Markowitz GS
Kidney Int; 2010 Dec; 78(11):1171-7. PubMed ID: 20811330
[TBL] [Abstract][Full Text] [Related]
6. Tenofovir-associated renal and bone toxicity.
Woodward CL; Hall AM; Williams IG; Madge S; Copas A; Nair D; Edwards SG; Johnson MA; Connolly JO
HIV Med; 2009 Sep; 10(8):482-7. PubMed ID: 19459988
[TBL] [Abstract][Full Text] [Related]
7. Tenofovir renal toxicity targets mitochondria of renal proximal tubules.
Kohler JJ; Hosseini SH; Hoying-Brandt A; Green E; Johnson DM; Russ R; Tran D; Raper CM; Santoianni R; Lewis W
Lab Invest; 2009 May; 89(5):513-9. PubMed ID: 19274046
[TBL] [Abstract][Full Text] [Related]
8. Acute kidney injury caused by tenofovir disoproxil fumarate and diclofenac co-administration.
Bickel M; Khaykin P; Stephan C; Schmidt K; Buettner M; Amann K; Lutz T; Gute P; Haberl A; Geiger H; Brodt HR; Jung O
HIV Med; 2013 Nov; 14(10):633-8. PubMed ID: 23980564
[TBL] [Abstract][Full Text] [Related]
9. Proximal tubular renal dysfunction or damage in HIV-infected patients.
Del Palacio M; Romero S; Casado JL
AIDS Rev; 2012; 14(3):179-87. PubMed ID: 22833061
[TBL] [Abstract][Full Text] [Related]
10. Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir.
Maggi P; Montinaro V; Bellacosa C; Pietanza S; Volpe A; Graziano G; Strippoli GF; Angarano G
AIDS Patient Care STDS; 2012 Jan; 26(1):5-11. PubMed ID: 22136504
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain.
Kruidering M; Van de Water B; de Heer E; Mulder GJ; Nagelkerke JF
J Pharmacol Exp Ther; 1997 Feb; 280(2):638-49. PubMed ID: 9023274
[TBL] [Abstract][Full Text] [Related]
12. Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy.
Perazella MA
Kidney Int; 2010 Dec; 78(11):1060-3. PubMed ID: 21076445
[TBL] [Abstract][Full Text] [Related]
13. Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity.
Sise ME; Hirsch JS; Canetta PA; Herlitz L; Mohan S
AIDS; 2015 May; 29(8):941-6. PubMed ID: 25784440
[TBL] [Abstract][Full Text] [Related]
14. Tenofovir alafenamide nephrotoxicity in an HIV-positive patient: A case report.
Novick TK; Choi MJ; Rosenberg AZ; McMahon BA; Fine D; Atta MG
Medicine (Baltimore); 2017 Sep; 96(36):e8046. PubMed ID: 28885375
[TBL] [Abstract][Full Text] [Related]
15. Incidence of proximal renal tubular dysfunction in patients on tenofovir disoproxil fumarate.
Quinn KJ; Emerson CR; Dinsmore WW; Donnelly CM
Int J STD AIDS; 2010 Feb; 21(2):150-1. PubMed ID: 20090006
[No Abstract] [Full Text] [Related]
16. Subcellular renal proximal tubular mitochondrial toxicity with tenofovir treatment.
Kohler JJ; Hosseini SH
Methods Mol Biol; 2011; 755():267-77. PubMed ID: 21761311
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of megalin and cubilin and altered mitochondrial activity in tenofovir nephrotoxicity.
Cez A; Brocheriou I; Lescure FX; Adam C; Girard PM; Pialoux G; Moestrup SK; Fellahi S; Bastard JP; Ronco P; Plaisier E
Hum Pathol; 2018 Mar; 73():89-101. PubMed ID: 29309806
[TBL] [Abstract][Full Text] [Related]
18. The case: 41-year-old HIV patient with proteinuria and progressive renal dysfunction. Tenofovir toxicity.
Agarwala R; Mohan S; Herlitz LC; Cheng JT
Kidney Int; 2010 Mar; 77(5):475-6. PubMed ID: 20150949
[No Abstract] [Full Text] [Related]
19. An investigation of the pattern of kidney injury in HIV-positive persons exposed to tenofovir disoproxil fumarate: an examination of a large population database (MHRA database).
Danjuma MI; Mohamad-Fadzillah NH; Khoo S
Int J STD AIDS; 2014 Mar; 25(4):273-9. PubMed ID: 24067251
[TBL] [Abstract][Full Text] [Related]
20. Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion.
Tanji N; Tanji K; Kambham N; Markowitz GS; Bell A; D'agati VD
Hum Pathol; 2001 Jul; 32(7):734-40. PubMed ID: 11486172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
